Efficacy and Safety of Filgotinib as Induction and Maintenance Therapy for Crohn's Disease: Results From the Phase 3 Randomized, Double-Blind, Placebo-Controlled DIVERSITY1 Study

被引：0

作者：

Vermeire, Severine ^{[1
]}

Rubin, David T. ^{[2
]}

Watanabe, Mamoru ^{[3
]}

Schreiber, Stefan ^{[4
]}

Mehta, Rajiv ^{[5
]}

Roblin, Xavier ^{[6
]}

Genovese, Mark C. ^{[7
]}

Masior, Tomasz ^{[8
]}

Barron, Rahul ^{[8
]}

Le Brun, Franck-Olivier ^{[8
]}

Danese, Silvio ^{[9
]}

机构：

[1] Univ Ziekenhuis Leuven, Leuven, Vlaams Brabant, Belgium

[2] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[3] Tokyo Med & Dent Univ, Adv Res Inst, Tokyo, Japan

[4] Univ Hosp Schleswig Holstein, Kiel, Schleswig Holst, Germany

[5] Digest Sci Hosp, Surat Inst, Surat, Gujarat, India

[6] Univ Hosp St Etienne, St Etienne, Pays De La Loir, France

[7] Gilead Sci Inc, Foster City, CA USA

[8] Galapagos GmbH, Basel, Basel Stadt, Switzerland

[9] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Milan, Lombardia, Italy

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S904

引用

下载

页码：S673 / S675

页数：3

共 50 条

[31] A PHASE 1/2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF THE INDUCTION OF CLINICAL RESPONSE AND REMISSION BY QBECO IN SUBJECTS WITH MODERATE TO SEVERE CROHN'S DISEASE
Gunn, Hal
Sutcliffe, Simon
Pankovich, Jim
Chen, Jenny M.
Vandermeirsch, Gillian
Thompson, Darby
Fedorak, Richard N.
Panaccione, Remo
Axler, Jeffrey L.
Bressler, Brian
GASTROENTEROLOGY, 2017, 152 (05) : S600 - S600
[32] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study
Zhang, Jianzhong
Gu, Jun
Zheng, Jie
Zheng, Min
Wang, Gang
Gu, Yihua
Okun, Martin
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
[33] Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-blind, Multicenter, Placebo-Controlled Phase 3 Study
Mueller, Daniel S.
Prinz, Valentina
Adelglass, Jeffrey
Cox, Sue Ellen
Gold, Michael H.
Kaufman-Janette, Joely
Nestor, Mark S.
Taylor, Susan
Frank, Konstantin
AESTHETIC SURGERY JOURNAL, 2022, 42 (06) : 677 - 688
[34] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
Hattori, N.
Takeda, A.
Takeda, S.
Nishimura, A.
Kitagawa, T.
Mochizuki, H.
Nagai, M.
Takahashi, R.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
[35] The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
Rogers, SL
Friedhoff, LT
Apter, JT
Richter, RW
Hartford, JT
Walshe, TM
Baumel, B
Linden, RD
Kinney, FC
Doody, RS
Borison, RL
Ahem, GL
DEMENTIA, 1996, 7 (06): : 293 - 303
[36] EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE 3 MONTH FORMULATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Berwaerts, Joris
Liu, Yanning
Gopal, Srihari
Nuamah, Isaac
Xu, Haiyan
Savitz, Adam
Coppola, Danielle
Schotte, Alain
Remmerie, Bart
Maruta, Nataliya
Hough, David W.
SCHIZOPHRENIA BULLETIN, 2015, 41 : S302 - S302
[37] Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
Feagan, B. G.
Rutgeerts, P. J.
Sands, B. E.
Colombel, J.
Sandborn, W. J.
Colombel, J.
Hanauer, S. B.
Van Assche, G. A.
Axler, J.
Kim, H.
Danese, S.
Fox, I.
Milch, C.
Sankoh, S.
Wyant, T.
Xu, J.
Parikh, A.
GASTROENTEROLOGY, 2012, 142 (05) : S160 - S161
[38] Results of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of astodrimer gel for prevention of recurrent bacterial vaginosis
Schwebke, J.
Carter, B.
Waldbaum, A.
Price, C.
Castellarnau, A.
Paull, J.
McCloud, P.
Kinghorn, G.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (06) : 672 - 673
[39] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab in Migraine Prevention: Primary Results of the ARISE Trial
Dodick, David
Ashina, Messoud
Kudrow, David
Lanteri-Minet, Michel
Osipova, Vera
Paler, Kerry
Picard, Hernan
Mikol, Daniel
Lenz, Robert
NEUROLOGY, 2017, 89 (08) : E98 - E98
[40] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
Tandon, R.
Loebel, A.
Phillips, D.
Pikalov, A.
Hernandez, D.
Mao, Y.
Cucchiaro, J.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154

← 1 2 3 4 5 →